FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug…
On May 21, 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug…
On May 11, 2011, University of British Columbia professor Connie Eaves was inducted into The Royal Society for…
On Apr. 26, 2021, Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s…
On Apr. 19, 2021, the Mayo Clinic announced a study that bolstered evidence that colorectal cancer is often…
On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…
On Apr. 15, 2021, CytoDyn announced it had executed an exclusive supply and distribution agreement with Chiral Pharma…
On Mar. 27, 2021, the U.S. Food and Drug Administration (FDA) announced it had approved Abecma (idecabtagene vicleucel),…
On Mar. 26, 2021, Bristol Myers Squibb and bluebird bio announced that the U.S. Food and Drug Administration…
On Mar. 22, 2021, AIM ImmunoTech announced that the Institutional Review Board (IRB) of Roswell Park Comprehensive Cancer…
On Mar. 3, 2021, TGen, an affiliate of City of Hope announced that an in-depth analysis of the…
On Feb. 10, 2021, Notch Therapeutics closed $85 Million Series A financing to develop pipeline of renewable stem…
On Jan. 12, 2021, a team researchers from the University of Texas Southwestern (UTSW) announced they had identified…
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
On Dec. 5, 2020, Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma…
On Nov. 24, 2020, Northwestern University researchers announced they had developed a new artificial intelligence (A.I.) platform that…
On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
On Aug. 5, 2020, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and…
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
On Jul. 22, 2020, BD (Becton, Dickinson) announced that it had received approval for a pre-market approval (PMA)…
On Jul. 21, 2020, researchers at the University of Cambridge have shown for the first time that genes…
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
On Jul. 9, 2020, Royal Philips announced it had formed a strategic collaboration with BioIntelliSense, a continuous health…
On Jul. 8, 2020, a Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh…